CK-19 also favored ICC (85,7% vs. 33.3% in HCC), with borderline significance (p = 0.0601), suggesting its complementary role in panels rather than as a standalone discriminator [59,60,61]. The gene discussed is KRT19; the disease is intrahepatic cholangiocarcinoma.